components’ C3 and C4. Cellular immunity integrated a total lymphocyte count and the delayed intradermal hypersensitivity test. The statistical analysis included Pearson’s Chi squared and non-parametric tests using
diagnosis relies upon an evocative clinical history and a confirmation by skin tests, especially intradermal tests. We report here a case of anaphylactic reaction to oxaliplatin. Besides the usual
malignant tumors, including skin cancer (squamous and basal cell), melanoma, breast cancer and their intradermal metastases, cancer of the mucous membranes (vulva, esophagus, bronchi, etc). With the aim of improving
volunteers were randomized in double-blind method into four groups (n=12) and three intradermal injections were made with respectively for each group 0, 11, 33, or 99ug
introduction of novel vaccine technologies currently under development in our company, such as the intradermal (ID) delivery system and a novel adjuvant. With regard to the ID delivery system, which
were randomized in four groups having at M0, M1 and M2 double blinded intradermal injections respectively with 0, 11, 33 or 99 μg of a synthetic protein called
treatment and outcome. All were immunized (BCG vaccine SSI, Copenhagen, Denmark, 0.05 ml injected intradermally in the left arm by a constant group of 3 trained nurses) within 48 hours
Combination of 25 μg LPS & 50μg OMPs with IFA, 3 times every 15 days, intradermally. 15 days after the last injection, blood samples were taken for Serum Bactericidal Assay
treatment and outcome. All were immunized (BCG vaccine SSI, Copenhagen, Denmark, 0.05 ml injected intradermally in the left arm by a constant group of 3 trained nurses) within 48 hours
Combination of 25 μg LPS & 50μg OMPs with IFA, 3 times every 15 days, intradermally. 15 days after the last injection, blood samples were taken for Serum Bactericidal Assay
Combination of 25 μg LPS & 50μg OMPs with IFA, 3 times every 15 days, intradermally. 15 days after the last injection, blood samples were taken for Serum Bactericidal Assay
adjuvants. Immunomodulatory activity was compared with Alum or MDP in experimental mice immunized by intradermal route with recombinant Candida albicans Hsp90 or Borrelia burgdorferi OspC. Using ELISA determination of…
more efficient promoters and codon optimization, addition of traditional or genetic adjuvants, electroporation, intradermal delivery and various prime-boost strategies. One of these strategies is controlled antigen…
investigation showed that illumination of the injection site for 10 ms prior to intradermal (ID) vaccination could enhance immune responses significantly against the vaccine. When imiquimod (ImiQ or ALDARA
tested for sterility and protein levelsmeasured by Lowry method. This crud antigen injected intradermally to Balb/c mice. We have one injection both two same booster doses with one week
dynamics of this clearance. To address this, we have immunized BALB/c mice intradermally with DNA-immunogens inducing strong Th1- (HIV-1 protease, PR) or Th2-shifted immune response
cell culture medium. BALB/c mice were immunized with RT gene chimera by intradermal injection followed by electroporation, and immune response was assessed by serology, IFN-g/IL-2 Fluorospot
spectrometry). The immunological properties of rHA antigen were tested in vivo. Mice were immunized intradermally with three doses of rHA (1, 5 and 25 μg) given at 3-weekly intervals
dimerization unit, and an antigenic unit (hemagglutinin). The vaccines were delivered by a single intradermal DNA injection, immediately followed by electroporation to increase cellular uptake and expression of DNA. Upon
delivery, as such, there is a need for cold chain during transportation. Secondly, intradermal (ID) and intramascular (IM) vaccination rely on trained personnel to perform these techniques. Finally, using needle
origin (H1,N1 from 2009, H3,N2 from 1968, NP,M from 1918)1. Intradermal immunisation with electroporation induced HI antibodies >40 HAI/ml between 7-10 days after second
TETADIF are longstanding. Produced is also PPD Tuberculin, ready to use for Mantoux’s intradermal test to assist in clinical diagnosis of tuberculosis. The improved from the WHO, vaccines give
hsp70 enhanced endocytosis of p24and activation of dendritic cells in vitro. After intradermal immunization of experimental mice with either p24, p24- hsp70, hsp70-p24 or hsp70, hsp70-p24 fusion protein
hyaluronic acid (11 mg/ml or 18 mg/ml). The drug was administered intradermally by the technique of papular injections with a 30 G needle, 2.0 ml per procedure
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.